Navigation Links
Cardium Reports on Exchange Listing With NYSE Alternext US
Date:12/30/2008

e visit http://www.t-r-co.com.

Cardium's Generx product candidate (alferminogene tadenovec, Ad5FGF-4) is a DNA-based growth factor therapeutic being developed for potential use by interventional cardiologists as a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more information about Cardium Therapeutics and its businesses, products and therapeutic candidates, please visit http://www.cardiumthx.com or view its 2007 Annual Report at http://www.cardiumthx.com/flash/pdf/CardiumAR07_Book_FINAL.pdf.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that the company can submit an acceptable plan for regaining compliance with exchange listing requirements or ultimately achieve such compliance even if a plan is accepted, that results observed in one study or using one type of product or procedure will be replicated in subsequent studies or in studies using newly-developed products or procedures, that planned product development efforts and clinical studies can be performed in an efficient and effective manner, that regulatory approvals can be obtained in a timely manner or at all, that partnering, distribution or other commercialization efforts can be achieved and if so that they will effectively accelerate InnerCool's patient temperature modulation business or market, that product modificatio
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. An international first at the CHUM - Promising treatment in regeneration of the myocardium through the use of stem cells
2. Cardium Reports on Recent Highlights and Financial Results
3. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
4. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
5. Cardium Completes $6.0 Million Financing
6. Cardium Announces Investor Presentation and Corporate Update Webcast
7. Cardium Reports on New York Citys Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Haemacure Reports Third Quarter 2007 Results
10. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased to ... Pharmacy Services at North Carolina State’s College of Veterinary ... Beal Award for Distinguished Volunteer Service—the organization’s highest award. ... contributions of volunteer experts to direct its work to ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Woodloch Pines, an ... has been selected by TripAdvisor as the number one best ... 6th best in the world for their annual Travelers’ Choice ... travel community . The website is home to millions of ...
(Date:1/22/2015)... Houston, TX (PRWEB) January 22, 2015 The ... Pro Bodybuilder Ben Pakulski to increase lean muscle by up ... This has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting ... shows that it is a step-by-step, scientific diet formula that ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2
... , , BOSTON, July 29 ... 2009, its annual summer scientific meeting, in Boston, July 29 - ... Anticipated attendance is more than 4,000. World-renowned leaders in the field ... diagnosis and medical, surgical and cosmetic treatment of skin, hair and ...
... , , MORRISTOWN, N.J., July ... leader in generic and specialty branded pharmaceuticals, today reported net income ... as detailed in the reconciliation table below, adjusted net income for ... an increase of $15.8 million or 29 percent. Adjusted EBITDA for ...
... , , , ... ) today announced that second quarter 2009 net income was $693.5 million, or ... income in the second quarter of 2008 was $750.5 million, or $1.44 per ... , "We are pleased with our earnings per share results for ...
... ... world , ... July 28, 2009 -- Announcing the first HelpDesk for GCP in the world. A much ... means to bring modern science and technology to diseased patients., , ,With the increase in ...
... Generation Rescue ... the autism community in order to help children and educate parents and medical professionals. , ... Los Angeles, CA (Vocus) July 29, 2009 -- ... meet the needs of the autism community in order to help children and educate parents and ...
... ... Provider Maximizes Performance with the TEDS Talent Management Suite. , ... Johnson City, TN (PRWEB) July 29, 2009 ... today the rollout of the TEDS® Talent Management Suite. TEDS is now live for ...
Cached Medicine News:Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 2Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 3Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 4Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 5Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 6Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 7Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 8Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 9Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 10Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 11Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 12Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 13Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 14Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 15Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 16Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 17Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 18Health News:Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 19Health News:WellPoint Reports Second Quarter 2009 Results 2Health News:WellPoint Reports Second Quarter 2009 Results 3Health News:WellPoint Reports Second Quarter 2009 Results 4Health News:WellPoint Reports Second Quarter 2009 Results 5Health News:WellPoint Reports Second Quarter 2009 Results 6Health News:WellPoint Reports Second Quarter 2009 Results 7Health News:WellPoint Reports Second Quarter 2009 Results 8Health News:WellPoint Reports Second Quarter 2009 Results 9Health News:WellPoint Reports Second Quarter 2009 Results 10Health News:WellPoint Reports Second Quarter 2009 Results 11Health News:WellPoint Reports Second Quarter 2009 Results 12Health News:WellPoint Reports Second Quarter 2009 Results 13Health News:WellPoint Reports Second Quarter 2009 Results 14Health News:WellPoint Reports Second Quarter 2009 Results 15Health News:WellPoint Reports Second Quarter 2009 Results 16Health News:WellPoint Reports Second Quarter 2009 Results 17Health News:WellPoint Reports Second Quarter 2009 Results 18
(Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, The ... support that prevents ankle sprains by cushioning the ankle ... fits securely around the outside of any shoe type ... comfort while still offering protection against sprains. With customers ...
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... Pharmaceuticals, Inc. (Nasdaq: AMPE ), a biopharmaceutical ... (Zertane™ completed two phase III studies, Ampion™-completed ... these drugs and engaged in further drug development, today ... the US Patent Office of an additional patent that ...
... March 19, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems ... an emerging leader in the development, assembly, marketing ... products, today announced its financial results for the ... (Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO ) ...
Cached Medicine Technology:Ampio Strengthens Patent Protection for Lead Drug Ampion™ 2Ampio Strengthens Patent Protection for Lead Drug Ampion™ 3Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 2Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 3Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 4Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 5Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 6Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 7Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 8Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 9Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 10Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 11Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 12Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 13Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 14Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 15
... Increased volume for use with 4, 8, ... bottom permits withdrawal of nearly all of the ... excess solution. Made of natural virgin polystyrene containing ... by irradiation. Dimensions: 78 mm W x 152 ...
Volume: 5 ml; Volume Graduation: 1/10 ml...
Precise, safe, and fatigue-free series pipetting using graduated pip...
An adhesive-backed hanger, designed for use where space is limited (fume hoods, sterile hoods, etc.). Sticks to any smooth, dry surface without damage. Resistant to chemicals and UV light....
Medicine Products: